Valuation (74%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 7.37 | N/A |
| PEG Ratio (TTM) | 12.53 | N/A |
| P/S Ratio (TTM) | 1.36 | N/A |
| P/B Ratio (TTM) | 1.99 | N/A |
| P/FCF Ratio (TTM) | 7.81 | N/A |
| Price to 5YR AVG Earnings Ratio | 14.08 | N/A |
| Price to 5YR AVG FCF Ratio | 10.35 | N/A |
Profitability (85%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 14.61% | N/A |
| ROE (TTM) | 28.96% | N/A |
| Net Profit Margin (TTM) | 18.57% | N/A |
| ROIC 5YR AVG | 36.11% | N/A |
Growth (85%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 12.71% | 42.50% | 286.10% |
| Revenue | -0.22% | 0.36% | 18.55% |
| Net Income | 10.63% | 63.48% | 299.99% |
| Cash Flow | 14.71% | 16.10% | 38.63% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.38 | N/A |
| Quick Ratio (TTM) | 1.16 | N/A |
| D/E Ratio (TTM) | 0.13 | N/A |
| Interest Coverage (TTM) | 26.40 | N/A |
| Piotroski F-Score | 8 | N/A |
| Altman Z-Score | 3.42 | N/A |
| LTL to 5YR AVG FCF | 0.67 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.20% | N/A |